针对默克尔细胞癌的当前和临床前治疗选择
Büke Celikdemir1, Roland Houben1, Thibault Kervarrec2
1Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.
Expert opinion on biological therapy
|September 11, 2023
概括
默克尔细胞癌 (MCC) 是一种罕见的皮肤癌. 免疫检查点抑制剂的进步为先进的MCC提供了生存益处,但耐药性仍然是一个挑战,需要对新疗法的进一步研究.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
背景情况:
- 默克尔细胞癌 (MCC) 是一种罕见的,具有神经内分泌特征的侵袭性皮肤癌.
- MCC的病因涉及不同的病毒和紫外线诱导的途径.
- 治疗选择有限和高死亡率强调了MCC研究进步的必要性.
研究的目的:
- 审查最近关于梅克尔细胞癌 (MCC) 治疗的临床前和临床研究.
- 为了强调正在进行的MCC研究的重要性.
- 强调开发MCC新型治疗策略的必要性.
主要方法:
- 对临床前和临床研究进行全面的文献搜索.
- 审查MCC治疗方式的最新进展.
- 在先进的MCC中分析免疫检查点抑制剂疗法.
主要成果:
- 免疫检查点抑制剂 (ICI) 为晚期MCC提供生存益处.
- 对ICI的原发性和获得性耐药性是MCC治疗中的一个重要问题.
- 抗PD-1/PD-L1疗法是目前基于证据的治疗先进的MCC.
结论:
- ICI疗法在治疗先进的MCC方面取得了重大进展.
- 解决治疗耐药性对于改善MCC患者的治疗结果至关重要.
- 进一步研究额外的治疗目标和方法对于MCC管理至关重要.
更多相关视频
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.4K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy
554
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Cancer Vaccines
399
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
399
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
